CNB Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.49M | Buy |
1,619
+166
| +11% | +$168K | 0.63% | 39 |
|
|
2025
Q4 | $1.56M | Buy |
1,453
+323
| +29% | +$309K | 0.64% | 36 |
|
|
2025
Q3 | $862K | Sell |
1,130
-62
| -5% | -$46.1K | 0.36% | 67 |
|
|
2025
Q2 | $929K | Sell |
1,192
-74
| -6% | -$57.5K | 0.44% | 57 |
|
|
2025
Q1 | $1.05M | Buy |
1,266
+11
| +0.9% | +$9.15K | 0.53% | 50 |
|
|
2024
Q4 | $969K | Buy |
1,255
+115
| +10% | +$95.2K | 0.45% | 58 |
|
|
2024
Q3 | $1.01M | Sell |
1,140
-29
| -2% | -$26.1K | 0.47% | 60 |
|
|
2024
Q2 | $1.06M | Buy |
1,169
+70
| +6% | +$56K | 0.51% | 52 |
|
|
2024
Q1 | $855K | Buy |
1,099
+123
| +13% | +$87.5K | 0.42% | 70 |
|
|
2023
Q4 | $569K | Buy |
976
+681
| +231% | +$398K | 0.31% | 91 |
|
|
2023
Q3 | $158K | Sell |
295
-290
| -50% | -$149K | 0.09% | 163 |
|
|
2023
Q2 | $274K | Sell |
585
-131
| -18% | -$54.9K | 0.16% | 127 |
|
|
2023
Q1 | $246K | Buy |
716
+131
| +22% | +$44.2K | 0.15% | 134 |
|
|
2022
Q4 | $214K | Hold |
585
| – | – | 0.13% | 136 |
|
|
2022
Q3 | $189K | Hold |
585
| – | – | 0.13% | 137 |
|
|
2022
Q2 | $190K | Hold |
585
| – | – | 0.12% | 140 |
|
|
2022
Q1 | $168K | Hold |
585
| – | – | 0.09% | 161 |
|
|
2021
Q4 | $162K | Hold |
585
| – | – | 0.09% | 156 |
|
|
2021
Q3 | $135K | Hold |
585
| – | – | 0.08% | 170 |
|
|
2021
Q2 | $134K | Buy |
585
+300
| +105% | +$60.3K | 0.08% | 173 |
|
|
2021
Q1 | $53K | Hold |
285
| – | – | 0.04% | 222 |
|
|
2020
Q4 | $48K | Hold |
285
| – | – | 0.04% | 223 |
|
|
2020
Q3 | $41K | Hold |
285
| – | – | 0.03% | 225 |
|
|
2020
Q2 | $47K | Hold |
285
| – | – | 0.04% | 220 |
|
|
2020
Q1 | $40K | Sell |
285
-123
| -30% | -$16.9K | 0.04% | 224 |
|
|
2019
Q4 | $54K | Hold |
408
| – | – | 0.05% | 217 |
|
|
2019
Q3 | $46K | Hold |
408
| – | – | 0.04% | 229 |
|
|
2019
Q2 | $45K | Buy |
408
+123
| +43% | +$14.5K | 0.04% | 220 |
|
|
2019
Q1 | $37K | Buy |
285
+60
| +27% | +$7.3K | 0.02% | 197 |
|
|
2018
Q4 | $26K | Hold |
225
| – | – | 0.02% | 200 |
|
|
2018
Q3 | $24K | Hold |
225
| – | – | 0.01% | 196 |
|
|
2018
Q2 | $19K | Hold |
225
| – | – | 0.01% | 203 |
|
|
2018
Q1 | $17K | Hold |
225
| – | – | 0.01% | 193 |
|
|
2017
Q4 | $19K | Buy |
+225
| New | +$19.1K | 0.01% | 198 |
|
Other funds holding LLY
VCM
VPM
CNB Bank's LLY Position: Q1 2026 in Review
CNB Bank increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $168K and bringing the position to 1,619 shares worth $1.49M. The position accounts for 0.63% of the portfolio, ranked #39.
CNB Bank first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.56M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- CNB Bank held 1,619 shares of Eli Lilly worth $1.49M as of Q1 2026.
- CNB Bank bought 166 Eli Lilly shares in Q1 2026, an estimated $168K.
- Eli Lilly made up 0.63% of CNB Bank's portfolio in Q1 2026, its #39 holding.
- CNB Bank first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- CNB Bank's Eli Lilly position peaked at $1.56M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.